Notice Designation: OF ASA Mandatory Business Case
Notice Designation: OF ASA Mandatory Business Case
·------- - -- -- -- ~ -
DAVID CHRISTIAN LUDWIG
and ARUZA, LLC,
Plaintiffs,
NOTICE OF DESIGNATION AS A
V.
MANDATORY BUSINESS CASE
DAMON LILLY,
Defendant.
Pursuant to N .C. Gen. Stat. § ?A-45.4, and within 30 days of service of the
comp laint, Defendant Damon Lilly designates this action as a mandatory complex
business case.
through counsel, certifies that this action meets the criteria for designation as a
Statutes.
are met:
2
North Carolina under Chapter 55, 55A, 55B, 57D, or 59 of
under a contract.
($1,000,000).
_____ (1) Involving a material issue related to tax law that has been
tax statute.
X (2) Described in subsection (1), (2), (3), (4), (5), or (8) of N.C.
involving trade secrets.” N.C. Gen. Stat. § 7A-45.4(a)(8). In addition, Plaintiffs allege
3
more than $10 million in damages. Compl. ¶ 14. Therefore, designation of this action
All pleadings filed to date in this action are attached. The complaint was filed
on March 30, 2020 and was served on Defendant on April 7, 2020. Therefore, this
notice is timely.
for Aptive Environmental, LLC, a leading pest-control company that delivers safe and
the agreement, Mr. Ludwig could not “divulge, disclose, furnish transmit, transfer,
required Mr. Ludwig to surrender all confidential information if his employment with
In February 2018, Mr. Ludwig left Aptive to start his own pest-control
company, Aruza, LLC. Id. ¶ 10; Compl. ¶ 6. In the course of starting his own pest-
control company, Mr. Ludwig breached his agreement with Aptive in multiple ways,
4
example, Aptive’s pay structure, compensation metrics, and diagrams—to develop
In May of 2018, Aptive filed a lawsuit against Mr. Ludwig in Utah state court.
Id. ¶ 12. The Utah lawsuit alleged that Mr. Ludwig had breached his employment
agreement with Aptive and violated Utah’s Uniform Trade Secrets Act. Id.
Under the terms of the settlement agreement, Aptive dismissed the Utah
lawsuit, and Mr. Ludwig agreed to pay Aptive $135,000. Id. ¶ 13. In addition, the
provides:
Five months after this release was executed, Plaintiffs filed this lawsuit
The complaint alleges a bevy of claims against Mr. Lilly based on alleged
conduct that occurred in the course of business competition between Aptive and
Aruza. The complaint alleges that the Plaintiffs held “proprietary and confidential
5
business information, including client and sales representative lists and sales
leaderboards, belonging to Aruza,” and that Mr. Lilly “induced Plaintiffs’ personnel
to divulge” those trade secrets. Compl. ¶ 12. The complaint also alleges that Mr.
Lilly attempted to persuade Aruza’s sales representatives to join Aptive in ways that
described above) when that lawsuit “had been resolved and any potential claims
The complaint asserts causes of action for defamation (Counts 1 and 2),
emotional-distress claims (Counts 3 and 4), violations of section 75-1.1 (Count 5),
tortious-interference claims (Counts 6 and 7), and a freestanding claim for punitive
damages (Count 8). The complaint did not plead a stand-alone cause of action for
violation of the North Carolina Trade Secrets Protection Act. As described more fully
as a predicate for their section 75-1.1 claim and, to at least some degree, as a predicate
DESIGNATION ANALYSIS
for cases that “involve a material issue related to . . . disputes involving trade secrets.”
N.C. Gen. Stat. § 7A-45.4(a)(8). Designation under this section does not require a
claim or counterclaim under the North Carolina Trade Secrets Protection Act. Relx,
Inc. v. Morrow, 2020 NCBC Order 13 ¶ 7; Relx, Inc. v. Morrow, 2020 NCBC Order 8.
6
individual causes of action themselves—dictate “[w]hether a case involves the
requisite dispute falling within the statutory requirements.”1 Relx, 2020 NCBC
Order 8 ¶ 7 (quoting Cornerstone Health Care, P.A. v. Moore, 2015 NCBC LEXIS 65,
put the existence, ownership, or misuse of alleged trade secrets at issue.” Id. ¶ 8
(quoting UNOX, Inc. v. Conway, 2019 NCBC LEXIS 41, at *7 (N.C. Super. Ct. June
28, 2019)); see also Relx, Inc. v. Morrow, 2020 NCBC Order 13 (same); see also, e.g.,
Here, the “complaint puts the existence, ownership, or misuse of alleged trade
First, the complaint alleges “the existence [and] ownership” of alleged trade
secrets. Relx, 2020 NCBC Order 8 ¶ 8 (quoting UNOX, 2019 NCBC LEXIS 41, at *7).
including client and sales representative lists and sales leaderboards belonging to
allegations described more fully below, create a material issue of whether the
1 The reason for this well-established rule is that the designation statute, N.C.
Gen. Stat. § 7A-45.4(a)(8), uses the words “including disputes arising under the
[Trade Secrets Protection Act],” thus indicating that the language of the statute “is
meant to be illustrative not exhaustive.” See Gurkin v. Sofield, 2019 NCBC Order 16
(quoting Jeffries v. Cty. of Harnett, 817 S.E.2d 36, 49 (N.C. Ct. App. 2018)).
7
whether it has “independent commercial value from not being generally known.” Ge
Betz, Inc. v. Conrad, 231 N.C. App. 214, 234, 752 S.E.2d 634, 649 (2013) (concluding
that certain sales data constituted a trade secret); see also, e.g., S. Fastening Sys. v.
Grabber Const. Prods., Inc., 2015 NCBC LEXIS 42, *11, 2015 WL 2031007 (N.C.
Super. Ct. 2015) (concluding that “confidential customer information” and “sales
Second, the complaint alleges “misuse of [the] alleged trade secrets” by Mr.
Lilly. See Relx, 2020 NCBC Order 8 ¶ 8 (quoting UNOX, 2019 NCBC LEXIS 41, at
*7). The complaint alleges that Mr. Lilly “induced Plaintiffs’ personnel to divulge”
these alleged trade secrets. Compl. ¶ 12. The complaint then relies on this alleged
75-1.1 claim. Indeed, the complaint explicitly alleges that Mr. Lilly violated section
75-1.1 by “seeking out and profiting from unlawfully acquired private business
information”—in other words, that his misappropriation of the alleged trade secrets
above is, by itself, a section 75-1.1 violation. Compl. ¶ 34; see also id. ¶ 12.
40, 45. They allege that, by acquiring Plaintiffs’ trade secrets, Mr. Lilly was able to
coerce “over one hundred total representatives” to leave Aruza and join Aptive—
conduct that Plaintiffs allege in support of their tortious interference claims. Compl.
¶¶ 13, 40, 45. They further allege that “but for” Mr. Lilly’s misuse of trade secrets
8
(among the other conduct alleged), employees would not have left Aruza for Aptive.
client and sales representative lists and sales leaderboards” is not a protected trade
secret under North Carolina law or, in the alternative, if Mr. Lilly did not
misappropriate these alleged trade secrets, it will have a major substantive effect on
Plaintiffs’ case. If Mr. Lilly prevails on either of those two issues, he will be absolved
tortious interference (Counts 6 and 7). In other words, for a court to resolve Plaintiffs’
exceed Ten Million Dollars,” designation was mandatory. See N.C. Gen. Stat. § 7A-
9
Respectfully submitted the 4th day of May, 2020.
10
CERTIFICATE OF SERVICE
I hereby certify that I have this day served a copy of the foregoing by depositing
a copy thereof in an envelope bearing sufficient postage in the United States mail,
addressed to the following person at the following address which is the last address
known to me:
J. Michael Genest
The Forge Law Group
1610 Hwy 70 E.
New Bern, NC 28560
Counsel for Plaintiffs
s/ Andrew H. Erteschik
Andrew H. Erteschik